Isobutylene oxide → HCID 63239148, compound
Reaction equation
[C:1]([N:9]1[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]1)(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(=O)([O-])[O-].[K+].[K+].[CH3:21][C:22]1([O:25][CH2:24]1)[CH3:23]>C(#N)C>[OH:25][C:22]([CH3:24])([CH3:23])[CH2:21][N:12]1[CH2:13][CH2:14][N:9]([C:1]([C:2]2[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=2)=[O:8])[CH2:10][CH2:11]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
500 mg (2.63 mmol) 1-benzoylpiperazine and 1.10 g (7.96 mmol, 3.0 eq.) potassium carbonate were suspended to 20 ml acetonitrile at room temperature. After adding 570 mg (7.90 mmol, 3.0 eq.) isobutylene oxide, it was heated at reflux and stirred overnight. After cooling to room temperature and adding 30 ml purified water, it was extracted twice with 30 ml ethylacetate. After collecting organic layer and drying with anhydrous magnesium sulfate, it was concentrated with decompression. The obtained residue was purified by chromatography using silicagel (mobile phase: dichloromethane/methanol=20:1) and 276 mg (40%) target compound as light-yellow solid was yielded.
Workup
- temperaturewas heated
- temperatureat reflux
- additionadding 30 ml
- custompurified water, it
- extractionwas extracted twice with 30 ml ethylacetate
- customAfter collecting organic layer
- dry with materialdrying with anhydrous magnesium sulfate, it
- concentrationwas concentrated with decompression
- customThe obtained residue was purified by chromatography
- custom276 mg (40%) target compound as light-yellow solid was yielded
Sources & evidence
- ORD record
- ord-4dc28ac386754abbba8c7e69549da59d
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08575173B2
Reaction notes
Loading…